Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026)

Updated

Dr Reddys Laboratories' Current Assets was $3.16 billion in the quarter ended Jun 30, 2026, up 0.3% from $3.15 billion a year earlier but down 4.3% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Current Assets at Dr Reddys Laboratories came in at $3.22 billion, up 9.9% from the prior year.

  • Current Assets shows a five-year compound annual growth rate of 9.7% (years ended Mar 2021 to Mar 2026).
  • In earlier years, Current Assets was $2.93 billion in the year ended Mar 31, 2025 (-1.6%), $2.98 billion in the year ended Mar 31, 2024 (+18.2%), $2.52 billion in the year ended Mar 31, 2023 (+5.0%) and $2.4 billion in the year ended Mar 31, 2022 (+18.3%).
  • Quarterly Current Assets has moved between $2.2 billion (the quarter ended Sep 30, 2022) and $3.34 billion (the quarter ended Dec 31, 2025) over five years.
  • Compared with a year earlier, Current Assets has increased for four straight quarters, with growth averaging 5.7% over the last eight quarters.
  • The best year-over-year quarter for Current Assets over five years was the quarter ended Jun 30, 2024 (growth of 26.1%); the worst was the quarter ended Mar 31, 2025 (a decline of 3.3%).
  • Per Business Quant data, RDY's Current Assets in the three quarters before the quarter ended Jun 30, 2026 was $3.3 billion (quarter ended Mar 31, 2026), $3.34 billion (quarter ended Dec 31, 2025) and $3.2 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn 3.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.16 Bn
Mar 31, 2026 3.30 Bn
Dec 31, 2025 3.34 Bn
Sep 30, 2025 3.20 Bn
Jun 30, 2025 3.15 Bn
Mar 31, 2025 2.89 Bn
Dec 31, 2024 3.00 Bn
Sep 30, 2024 2.96 Bn
Jun 30, 2024 3.23 Bn
Mar 31, 2024 2.99 Bn
Dec 31, 2023 2.86 Bn
Sep 30, 2023 2.63 Bn
Jun 30, 2023 2.56 Bn
Mar 31, 2023 2.48 Bn
Dec 31, 2022 2.37 Bn
Sep 30, 2022 2.20 Bn
Jun 30, 2022 2.33 Bn
Mar 31, 2022 2.42 Bn
Dec 31, 2021 2.23 Bn
Sep 30, 2021 2.20 Bn
API Access

Dr Reddys Laboratories Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=RDY&period=max&api_key=YOUR_API_KEY